Loading…
4 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| GM Pharmaceuticals | Pharma | 33.6% | 81st pct | 110 |
| Alpha | (unclassified) | 28.3% | 78th pct | 1208 |
| Sports Saiens Georgia | Fitness & Wellness | 1.0% | 47th pct | 30 |
| PSP Pharma | Pharma | 6.8% | 30th pct | 110 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
| Line item | PSP Pharma | GM Pharmaceuticals | Sports Saiens Georgia | Alpha |
|---|---|---|---|---|
| Total Current Assets | 392,371 | 202,180 | 97 | 731 |
| Total Non-Current Assets | 274,633 | 60,873 | 2,440 | 579 |
| TOTAL ASSETS | 667,004 | 263,052 | 2,537 | 1,309 |
| Total Current Liabilities | 248,714 | 15,021 | 75 | 52 |
| Total Non-Current Liabilities | 94,055 | 365 | 25 | 0 |
| TOTAL LIABILITIES | 342,769 | 15,386 | 100 | 52 |
| Total Equity | 324,235 | 247,667 | 2,437 | 1,257 |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 |
| Total Debt | 112,540 | 738 | 25 | 0 |
| Cash & Equivalents | 20,687 | 47,348 | 3 | 560 |
| Net Debt | 91,853 | -46,609 | 22 | -560 |